Back
Capricor Therapeutics Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
25
CAPR
Capricor Therapeutics
Last Price:
$7.31
Seasonality Move:
5.63%
7 Day Trial
ALL ACCESS PASS
$
7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Capricor Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.69 | Sell |
20-day SMA: | 10.65 | Sell |
50-day SMA: | 11.32 | Sell |
200-day SMA: | 12.28 | Sell |
8-day EMA: | 8.32 | Sell |
20-day EMA: | 9.83 | Sell |
50-day EMA: | 11.19 | Sell |
200-day EMA: | 11.59 | Sell |
Capricor Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.14 | Sell |
Relative Strength Index (14 RSI): | 32.95 | Sell |
Chaikin Money Flow: | 2172950 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.03 - 12.65) | Sell |
Bollinger Bands (100): | (10.55 - 15.03) | Sell |
Capricor Therapeutics Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Capricor Therapeutics Stock
Is Capricor Therapeutics Stock a Buy?
-
Capricor Therapeutics share price is 7.11 while CAPR 8-day simple moving average is 8.69, which is a Sell signal.
-
The stock price of CAPR is 7.11 while Capricor Therapeutics 20-day SMA is 10.65, which makes it a Sell.
-
Capricor Therapeutics 50-day simple moving average is 11.32 while CAPR share price is 7.11, making it a Sell technically.
-
CAPR stock price is 7.11 and Capricor Therapeutics 200-day simple moving average is 12.28, creating a Sell signal.
CAPR Technical Analysis vs Fundamental Analysis
Sell
25
Capricor Therapeutics (CAPR)
is a Sell
Is Capricor Therapeutics a Buy or a Sell?
-
Capricor Therapeutics stock is rated a SellThe current Capricor Therapeutics [CAPR] share price is $7.11. The Score for CAPR is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Capricor Therapeutics Stock Info
Market Cap:
324.8M
Price in USD:
7.11
Share Volume:
3.5M
Capricor Therapeutics 52-Week Range
52-Week High:
23.40
52-Week Low:
3.52
Sell
25
Capricor Therapeutics (CAPR)
is a Sell
Capricor Therapeutics Share Price Forecast
-
What is the Capricor Therapeutics stock price today?The Capricor Therapeutics stock price is 7.11 USD today.
-
Will CAPR stock go up or go down?Capricor Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Capricor Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Capricor Therapeutics is overvalued.
Is Capricor Therapeutics Stock a Buy?
-
Capricor Therapeutics share price is 7.11 while CAPR 8-day exponential moving average is 8.32, which is a Sell signal.
-
The stock price of CAPR is 7.11 while Capricor Therapeutics 20-day EMA is 9.83, which makes it a Sell.
-
Capricor Therapeutics 50-day exponential moving average is 11.19 while CAPR share price is 7.11, making it a Sell technically.
-
CAPR stock price is 7.11 and Capricor Therapeutics 200-day simple moving average is 11.59, creating a Sell signal.
Fundamental Analysis of Capricor Therapeutics
Is Capricor Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.65 per share, an increase this year of $0.82 per share, and an increase next year of $0.18 per share.
Technical Analysis of Capricor Therapeutics
Should I short Capricor Therapeutics stock?
-
CAPR Moving Average Covergence Divergence (MACD) indicator is -1.14, suggesting Capricor Therapeutics is a Sell
-
Capricor Therapeutics Relative Strength Index (RSI) is 32.95, which suggest Capricor Therapeutics is oversold
-
The Bollinger Bands (25) for Capricor Therapeutics is (8.03 - 12.65), which suggest Capricor Therapeutics is a Sell
-
The Bollinger Bands (100) for Capricor Therapeutics is (10.55 - 15.03), which suggest Capricor Therapeutics is a Sell
* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.